SCHEMBL18164150

SCHEMBL18164150

C[C@@H]1O[C@@H](OCCNC(=O)CN(CC(=O)NCCO[C@H]2OC(CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H]2O)C(=O)CCCCC(=O)Nc2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ FGF1 P05230 8/20 0.40
▸ VEGFA P15692 6/20 0.40
▸ FGF2 P09038 3/20 0.40
▸ HPSE Q9Y251 2/20 0.40
▸ CD209 Q9NNX6 2/20 0.40
▸ SELE P16581 1/20 0.39
▸ SELP P16109 1/20 0.38
▸ MDK P21741 1/20 0.38
▸ MMP2 P08253 1/20 0.37
▸ MMP3 P08254 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ MMP12 P39900 1/20 0.37
▸ PRKCA P17252 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18056168 1.00 MMP13 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL16644758 0.92 MMP13 (0.47) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL19860903 0.89 CD209 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL19860868 0.89 CD209 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL16640814 0.89 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL16640822 0.89 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL18161289 0.89 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL18056139 0.88 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL16644897 0.88 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1
SCHEMBL16644871 0.88 FGF1 (0.42) MMP13ALDH1A1CYP3A4ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2016-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES GPR119, INSR, IRS1 MMP13 3215/4885ALDH1A1 3285/4885CYP3A4 1382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback